18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.

Kiran M. Y., Has Simsek D., Sanli Y., Kuyumcu S.

Clinical nuclear medicine, vol.48, no.2, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 48 Issue: 2
  • Publication Date: 2023
  • Doi Number: 10.1097/rlu.0000000000004532
  • Journal Name: Clinical nuclear medicine
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Istanbul University Affiliated: Yes

Abstract

A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent (18)FDG PET/CT and Ga-68-FAPI (fibroblast activated protein inhibitor)-04 PET/CT scans. Ga-68-FAPI-04 PET/CT outperformed (18)FDG PET/CT demonstrating higher uptake in the metastatic lesions.